<DOC>
	<DOCNO>NCT01863277</DOCNO>
	<brief_summary>The purpose study evaluate effect Melatonin ( dosage 14mg daily ) well clinical outcome period three day post stroke .</brief_summary>
	<brief_title>Safety Study Melatonin Stroke Patients</brief_title>
	<detailed_description>Stroke third common cause stroke . The cascade event separate hyperacute , ,acute , sub-acute chronic . In acute , sub acute state mechanism inflammation apoptotic death effect free radical . Melatonin prove effect mechanism favourable effect different disease . The aim study prove That use Melatonin high dosage may anti-destructive effect stoke .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>within 72hours ischemic stroke age 1880 gender ability sign consent form intracerebral bleed tumour brain multiple sclerosis s/p craniotomy know allergy melatonin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>